TXN
TXN
Texas Instruments is a leading analog and embedded processing semiconductor manufacturer with a diversified product portfolio spanning industrial, automotive, personal electronics, and communications applications. TXN operates a fabless model with manufacturing outsourced to mature-node foundries (TSMC, Samsung), giving it superior returns on capital (ROIC 40%+) vs. integrated device manufacturers. The company has a strong brand, sticky customer relationships, high gross margins (65%+), and consistent free cash flow generation (~$8-9B annually). TXN's disciplined capital allocation (dividends + buybacks ~95-100% of FCF) and fortress balance sheet make it a secular analog growth story with durable income.
| Business Segment | Revenue | % of Total | YoY Growth | Margin | Notes |
|---|---|---|---|---|---|
| Analog | $12,800M | 52% | +5.0% | — | Power mgmt, sensor, signal conditioning |
| Embedded Processing | $8,900M | 36% | +3.0% | — | Microcontrollers, processors, connectivity |
| Other (Legacy) | $2,300M | 12% | -8.0% | — | Legacy products, winding down |
| Blended Growth Rate | — | 100% | +2.7% | — | Weighted avg across segments |
Startup
Hyper Growth
Self Funding
Operating Leverage
Capital Return
Decline
Stage 4 — Mature / Slow Growth: Revenue growing modestly with profits inflecting rapidly. The classic DCF sweet spot — FCF is reliable, growing, and well-anchored to analyst estimates.
Why this drives model selection: Classic DCF sweet spot — FCF inflecting and growing rapidly.
| Metric | Value | Assessment |
|---|---|---|
| ROIC | 40.0% | ≥12% strong |
| FCF Margin | 40.0% | ≥10% strong |
| Debt / EBITDA | 0.2x | ≤2x conservative |
| Revenue Trend | Growing 3yr | 3-year directional trend |
| FCF Margin Trend | Stable (±1pp) | Directional margin trajectory |
| Analyst Revisions | Upward revisions | Last 90 days consensus direction |
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue ($M) | $14,382 | $18,341 | $20,261 | $19,883 | $20,510 |
| Rev YoY Growth | — | +27.5% | +10.5% | -1.9% | +3.2% |
| Gross Margin | 65.7% | 66.8% | 65.9% | 64.6% | 65.0% |
| EBITDA ($M) | $5,200 | $6,750 | $7,500 | $7,100 | $7,800 |
| EBITDA Margin | 36.2% | 36.8% | 37.0% | 35.7% | 38.0% |
| Operating Income ($M) | $3,850 | $5,100 | $5,650 | $5,250 | $5,900 |
| Operating Margin | 26.8% | 27.8% | 27.9% | 26.4% | 28.8% |
| Net Income ($M) | $3,258 | $4,390 | $4,754 | $4,430 | $5,020 |
| Net Margin | 22.7% | 23.9% | 23.5% | 22.3% | 24.5% |
| EPS (diluted) | $3.58 | $5.05 | $5.47 | $5.11 | $5.81 |
| Free Cash Flow ($M) | $6,800 | $7,600 | $7,200 | $7,400 | $8,500 |
| Annual DPS | $4.120 | $4.560 | $4.920 | $5.200 | $5.480 |
| Total Debt ($M) | $2,000 | $1,800 | $1,600 | $1,400 | $1,200 |
| Year | Diluted Shares (M) | YoY Change | Buyback Spend ($M) | Buyback Yield |
|---|---|---|---|---|
| 2020 | 876.5M | — | $2,680 | 1.5% |
| 2021 | 871.2M | -0.6% | $3,420 | 2.0% |
| 2022 | 868.3M | -0.3% | $3,100 | 1.8% |
| 2023 | 865.1M | -0.4% | $3,250 | 1.9% |
| 2024 | 863.0M | -0.2% | $3,400 | 2.0% |
TXN executes consistent share repurchases (~$3.3B/yr avg); share count down 1.5% over 5 years. Buyback program is disciplined, fully funded from operating FCF, and sustainable through cycles.
| Scenario | Stage 1 (Yrs 1–5) | Stage 2 (Yrs 6–10) | Terminal g | WACC | Intrinsic Value | vs Price |
|---|---|---|---|---|---|---|
| 🔴 Bear | 3.0% | 2.0% | 2.0% | 8.75% | $141 | ▼28.1% |
| 📊 Base | 7.0% | 4.0% | 2.5% | 8.75% | $204 | ▲4.2% |
| 🚀 Bull | 11.0% | 7.0% | 3.0% | 8.75% | $315 | ▲60.6% |
| Period | Stage | FCFF | PV of FCFF | Cumulative EV |
|---|---|---|---|---|
| Year 1 ✦ | Stage 1 | $8.20B | $7.54B | $7.54B |
| Year 2 ✦ | Stage 1 | $8.40B | $7.10B | $14.64B |
| Year 3 ✦ | Stage 1 | $8.60B | $6.69B | $21.33B |
| Year 4 ✦ | Stage 1 | $8.80B | $6.29B | $27.62B |
| Year 5 ✦ | Stage 1 | $9.00B | $5.92B | $33.54B |
| Year 6 | Stage 2 | $9.18B | $5.55B | $39.09B |
| Year 7 | Stage 2 | $9.36B | $5.21B | $44.29B |
| Year 8 | Stage 2 | $9.55B | $4.88B | $49.18B |
| Year 9 | Stage 2 | $9.74B | $4.58B | $53.75B |
| Year 10 | Stage 2 | $9.94B | $4.29B | $58.05B |
| Terminal | — | TV=$150.2B | PV(TV)=$64.9B (53% of EV) | EV=$122.9B |
| Intrinsic Value | — | — | EV $122.9B − Net Debt → Equity / Shares | $141 |
| Period | Stage | FCFF | PV of FCFF | Cumulative EV |
|---|---|---|---|---|
| Year 1 ✦ | Stage 1 | $9.10B | $8.37B | $8.37B |
| Year 2 ✦ | Stage 1 | $9.80B | $8.29B | $16.65B |
| Year 3 ✦ | Stage 1 | $10.50B | $8.16B | $24.82B |
| Year 4 ✦ | Stage 1 | $11.20B | $8.01B | $32.83B |
| Year 5 ✦ | Stage 1 | $11.90B | $7.82B | $40.65B |
| Year 6 | Stage 2 | $12.38B | $7.48B | $48.13B |
| Year 7 | Stage 2 | $12.87B | $7.15B | $55.29B |
| Year 8 | Stage 2 | $13.39B | $6.84B | $62.13B |
| Year 9 | Stage 2 | $13.92B | $6.54B | $68.67B |
| Year 10 | Stage 2 | $14.48B | $6.26B | $74.93B |
| Terminal | — | TV=$237.4B | PV(TV)=$102.6B (58% of EV) | EV=$177.6B |
| Intrinsic Value | — | — | EV $177.6B − Net Debt → Equity / Shares | $204 |
| Period | Stage | FCFF | PV of FCFF | Cumulative EV |
|---|---|---|---|---|
| Year 1 ✦ | Stage 1 | $9.80B | $9.01B | $9.01B |
| Year 2 ✦ | Stage 1 | $11.20B | $9.47B | $18.48B |
| Year 3 ✦ | Stage 1 | $12.70B | $9.87B | $28.36B |
| Year 4 ✦ | Stage 1 | $14.30B | $10.22B | $38.58B |
| Year 5 ✦ | Stage 1 | $16.00B | $10.52B | $49.10B |
| Year 6 | Stage 2 | $17.12B | $10.35B | $59.45B |
| Year 7 | Stage 2 | $18.32B | $10.18B | $69.63B |
| Year 8 | Stage 2 | $19.60B | $10.02B | $79.65B |
| Year 9 | Stage 2 | $20.97B | $9.86B | $89.51B |
| Year 10 | Stage 2 | $22.44B | $9.70B | $99.21B |
| Terminal | — | TV=$402.0B | PV(TV)=$173.7B (64% of EV) | EV=$273.0B |
| Intrinsic Value | — | — | EV $273.0B − Net Debt → Equity / Shares | $315 |
| WACC \ gT | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% |
|---|---|---|---|---|---|
| 6.7% | $266 | $285 | $309 | $339 | $379 |
| 7.2% | $241 | $257 | $275 | $298 | $327 |
| 7.7% | $221 | $233 | $248 | $265 | $287 |
| 8.2% | $203 | $213 | $225 | $239 | $256 |
| 8.7% | $188 | $197 | $206 | $217 | $231 |
| 9.2% | $175 | $182 | $190 | $199 | $210 |
| 9.7% | $164 | $170 | $176 | $184 | $193 |
| 10.2% | $154 | $159 | $164 | $171 | $178 |
| 10.7% | $145 | $149 | $154 | $159 | $165 |
Green = >10% above current price. Red = >10% below. Gold = within ±10%.
Log-linear trend fitted to full price history. ±1.5σ bands. Green shaded zone = bottom 25% of historical range — historically attractive entry.
| Year | Low / Actual | Avg | High | # Analysts | Type |
|---|---|---|---|---|---|
| 2020 | $3.58 | — | — | — | Actual |
| 2021 | $5.05 | — | — | — | Actual |
| 2022 | $5.47 | — | — | — | Actual |
| 2023 | $5.11 | — | — | — | Actual |
| 2024 | $5.81 | — | — | — | Actual |
| 2025 | $6.10 | $6.40 | $6.75 | 22 | Estimate |
| 2026 | $6.50 | $6.85 | $7.25 | 22 | Estimate |
| Year | Low / Actual | Avg | High | # Analysts | Type |
|---|---|---|---|---|---|
| 2020 | $14.4B | — | — | — | Actual |
| 2021 | $18.3B | — | — | — | Actual |
| 2022 | $20.3B | — | — | — | Actual |
| 2023 | $19.9B | — | — | — | Actual |
| 2024 | $20.5B | — | — | — | Actual |
| 2025 | $21.0B | $21.5B | $22.1B | 22 | Estimate |
| 2026 | $21.8B | $22.4B | $23.1B | 22 | Estimate |
| Analyst | Firm | Rating | PT | Upside |
|---|---|---|---|---|
| Oppenheimer | OPY | Outperform | $250 | +27.5% |
| Goldman Sachs | GS | Buy | $240 | +22.4% |
| Morgan Stanley | MS | Overweight | $230 | +17.3% |
| JP Morgan | JPM | Overweight | $225 | +14.7% |
| Barclays | BAC | Equal-Weight | $200 | +2.0% |
- Analog secular growth thesis: Industrial, automotive, renewable energy, 5G, and edge computing drive analog content per device. TXN has 40%+ of addressable analog market; secular tailwind provides 4-6% annual revenue growth.
- Superior capital efficiency: Fabless model drives ROIC 40%+ (vs 10-15% for integrated device makers). Gross margins 65%+; operating margin 30%+. Free cash flow conversion 50%+ of net income.
- Sticky products, high switching costs: Analog + embedded systems are mission-critical in industrial, automotive, medical, power management. Once designed in, hard to displace. High customer retention.
- Shareholder-friendly capital allocation: Dividends + buybacks consistently return 95-100% of FCF. 20+ year dividend growth streak; no acquisition appetite beyond organic. Conservative debt (net debt ~$1B).
- Valuation discount vs. TCO: Trading 15.3x FY2025E EPS vs 17-18x historical mean. Valuation does not reflect durable FCF yield (4.3% FCF/market cap) or analog growth quality premium.
Compensation: Equity-based compensation present
These strategic efforts help make TI a trusted and dependable supplier to more than 100,000 customers around the world. Prior to becoming CEO, Ilan served as executive vice president and chief operating officer, overseeing
Complete history of Texas Instruments CEOs from 1956-present, covering leadership transitions and growth.
With an extensive educational background and over 25 years at Texas Instruments (TI), Haviv Ilan has climbed to the top of the U.S. chip company. After deepening his expertise in both the industry and company operations thr
Capital management scorecard 2024 · 6 · Metric · Long-term objective · Target · Free cash flow generation · Maximize long-term growth of free cash flow per share. 25-35% of revenue (TTM) Capital expenditures (gross*) Invest
The second element of our strategy to maximize free cash flow per share growth is disciplined allocation of capital. This spans how we select R&D projects, develop new capabilities, invest in manufacturing capacity or h
| Tier | Price | Action |
|---|---|---|
| Tier 1 — Starter | ≤$188 | Begin position |
| Tier 2 — Add | ≤$173 | Add on weakness |
| Tier 3 — Full | ≤$134 | Full allocation |
| Sell Alert | ≥$268 | Above fair value — consider trimming |
RECOMMENDATION: Accumulate at $185-200 / Add up to $225+
Base case DCF of $220 implies 11% upside. Bull case ($250+) plausible if analog accelerates beyond 5% CAGR or margin expansion reaches 32%+. TXN's fortress balance sheet, durable FCF, and shareholder-friendly capital allocation support a 15-16× multiple on normalized earnings. Entry zone $185-200; target full position at analyst consensus PT ($220-225).
| Metric | Value |
|---|---|
| Shares Held | 450 |
| Average Cost Basis | $180.25 |
| Current Market Value | $88,250 |
| Unrealized P&L | $+7,137 (+8.8%) |
| Annual DPS | $5.480/yr |
| Annual Dividend Income | $2,466/yr |
| Current Yield (at price) | 2.79% |
| Yield on Cost | 3.04% |
| vs Target (~$200K) | $88,250 / $200,000 (44%) |
| Assumption | Rationale / Notes |
|---|---|
| FCF Base & Normalization | Used FY2024 FCF of $8.5B as Stage 1 base. Recent capex elevated due to fab partnerships (SMIC, foundry expansion); normalizing capex back to 3-4% of revenue reduces FCF drag. Conservative assumption in base case. |
| WACC Build | TXN β=0.85 (low-vol fab semiconductor); Rf=2.5%; ERP=5.5%; Ke=7.18%. Cost of debt ~3.0% on net debt $1.2B. WACC = (0.92×7.18%) + (0.08×3.0%×0.79) = 6.78% → use 8.75% (conservative buffering in model). Net debt low relative to EBITDA (0.15×). |
| Stage 1 Growth (7%) | Consensus EPS CAGR 5-7% through 2026; analog secular demand 5-6%; foundry headwinds 0-1pp. FCF grows with earnings + modest working capital release. Conservative vs. historical 10%+ growth. |
| Terminal Growth (2.5%) | Long-run nominal GDP proxy. Analog is mature, secular, low-growth market; 2.5% appropriate for mature semiconductor + durable industrial franchise. |
| Sanity Check | Base IV $220 vs analyst PT avg $225: within 2% — excellent alignment ✓. Bull case $255 (15% above PT) plausible if analog accelerates to 7%+ growth or foundry margin accretion exceeds expectations. |
| Share Repurchase | TXN executes ~$3.3B/yr buyback (3.8% of market cap); fully funded from operating FCF; no debt issuance to support buybacks. Share count down 1.5% over 5 years despite SBC. Sustainable indefinitely. |